BioCorRx Announces Formation of Scientific Advisory Board
BIOCORRX INC NEW (BICX)
NASDAQ:AMEX Investor Relations:
ir.biocorrx.com
Company Research
Source: GlobeNewswire
ANAHEIM, CA, Feb. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use disorders, announced today the formation of its Scientific Advisory Board (SAB) with three key appointments: David R. Gastfriend, M.D., DFASAM, Evgeny Krupitsky M.D., Ph.D., D.M.Sc., and George E. Woody, M.D. The SAB will work closely with BioCorRx’s management team as it actively continues to advance its lead product candidate, BICX102, a multi-month sustained release naltrexone implant for the treatment of opioid and alcohol use disorders. The Company was recently awarded approximately $5.7 million from the National Institute on Drug Abuse (NIDA) for further development of BICX102. David R. Gastfriend M.D., commented, “In the midst of the U.S. opioid epidemic, the opportunity to improve access and overcome patients’ short-term persistence on existing agents is a crucial national need.
Show less
Read more
Impact Snapshot
Event Time:
BICX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BICX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BICX alerts
High impacting BIOCORRX INC NEW news events
Weekly update
A roundup of the hottest topics
BICX
News
- BioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and Schizophrenia [Yahoo! Finance]Yahoo! Finance
- BioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and SchizophreniaGlobeNewswire
- BioCorRx Reports Business Update for 2023 [Yahoo! Finance]Yahoo! Finance
- BioCorRx Reports Business Update for 2023GlobeNewswire
- BioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for Research on BICX104, a Naltrexone Implant in Combination with Bupropion for the Treatment of MUD [Yahoo! Finance]Yahoo! Finance
BICX
Sec Filings
- 5/1/24 - Form 4
- 4/5/24 - Form 4
- 4/3/24 - Form 8-K
- BICX's page on the SEC website